Top FDA Officials Reject Call To Halve COVID-19 Doses In Order To Distribute More Widely

Top FDA Officials Reject Call To Halve COVID-19 Doses In Order To Distribute More Widely


Two top officials with the Food and Drug Administration (FDA) have announced they oppose a plan to cut the dosage of a COVID-19 vaccine in half, saying the move is “premature.”

On Sunday, Moncef Slaoui, chief scientific adviser of Operation Warp Speed, a vaccine program established by President Donald Trump, said half a dose of the Moderna vaccine is just as effective as a full dose. “We know that for the Moderna vaccine, giving half of the dose to people between the ages of 18 and 55, two doses, half the dose, which means exactly achieving the objective of immunizing double the number of people with the doses we have,” Slaoui said on CBS’ “Face the Nation.”

“We know it induces identical immune response” to the full dose, he added. With vaccines in short supply, Slaoui suggested cutting the vaccine doses in half was “a more responsible approach that would be based on facts and data.”

Trending: New Evidence Emerges: Capitol Police Officer Did Not Die From Fire Extinguisher

But FDA Commissioner

Continue reading

You Might Like

Do NOT follow this link or you will be banned from the site!
Send this to a friend